Personal profile
OECD Fields of Science
- 1.3 Physical Sciences
- 1.4 Chemical Sciences
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 7 Affordable and Clean Energy
Fingerprint
Dive into the research topics where Edgars Sūna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chiral Epoxy-Imine Building Block for Diversity-Oriented Synthesis of Peptidomimetic Aspartic Protease Inhibitors
Kovada, V., Pulle, T. & Suna, E., 1 Aug 2025, In: Journal of Organic Chemistry. 90, 30, p. 10771-10785 15 p.Research output: Contribution to journal › Article › peer-review
-
Entry to 2-aminoprolines via electrochemical decarboxylative amidation of N‑acetylamino malonic acid monoesters
Koleda, O., Sadauskis, J., Antonenko, D., Treijs, E. J., Steberis, R. D. & Suna, E., 2025, In: Beilstein Journal of Organic Chemistry. 21, p. 630-638 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity (Cell (2025) 188(19) (5142–5156.e23), (S0092867425006300), (10.1016/j.cell.2025.05.042))
Motso, A., Pelcman, B., Kalinovich, A., Kahlous, N. A., Bokhari, M. H., Dehvari, N., Halleskog, C., Waara, E., de Jong, J., Cheesman, E., Kallenberg, C., Yakala, G. K., Murad, P., Wetterdal, E., Andersson, P., van Beek, S., Sandström, A., Alleluia, D. N., Talamonti, E. & Youhanna, S. & 28 others, , 18 Sept 2025, In: Cell. 188, 19, p. 5429-5431 3 p.Research output: Contribution to journal › Comment/debate/note
Open Access1 Citation (Scopus) -
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity
Motso, A., Pelcman, B., Kalinovich, A., Kahlous, N. A., Bokhari, M. H., Dehvari, N., Halleskog, C., Waara, E., de Jong, J., Cheesman, E., Kallenberg, C., Yakala, G. K., Murad, P., Wetterdal, E., Andersson, P., van Beek, S., Sandström, A., Alleluia, D. N., Talamonti, E. & Youhanna, S. & 28 others, , 18 Sept 2025, In: Cell. 188, 19, p. 5142-5156.e23Research output: Contribution to journal › Article › peer-review
Open Access16 Citations (Scopus) -
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria
Huseby, D. L., Cao, S., Zamaratski, E., Sooriyaarachchi, S., Ahmad, S., Bergfors, T., Krasnova, L., Pelss, J., Ikaunieks, M., Loza, E., Katkevics, M., Bobileva, O., Cirule, H., Gukalova, B., Grinberga, S., Backlund, M., Simoff, I., Leber, A. T., Berruga-Fernández, T. & Antonov, D. & 12 others, , 9 Apr 2024, In: Proceedings of the National Academy of Sciences of the United States of America. 121, 15, e2317274121.Research output: Contribution to journal › Article › peer-review
Open Access24 Citations (Scopus)